BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6172579)

  • 1. Stabilizing action of disodium cromoglycate on erythrocyte membrane.
    Kuriyama K; Okuno T
    J Pharmacobiodyn; 1981 Oct; 4(10):779-87. PubMed ID: 6172579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of a new antiallergic agent, KP-136 on mast cell activation: a comparison with disodium cromoglycate.
    Kuriyama K; Hiyama Y; Ito K; Yoshinaka I; Bito Y
    Agents Actions; 1988 Dec; 25(3-4):321-5. PubMed ID: 3146215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane stabilizing action of NCO-650 and its congeners.
    Arakawa K; Tonooka M; Goto H; Sakamoto K
    Jpn J Pharmacol; 1984 Nov; 36(3):311-8. PubMed ID: 6441049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.
    Kazimierczak W; Gonzalez Alvarez R; Maśliński C
    Agents Actions; 1980 Apr; 10(1 Pt 2):8-14. PubMed ID: 6155773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
    Mackay GA; Pearce FL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium cromoglycate inhibition of substance P-induced histamine secretion is calcium dependent.
    Nishibori M; Saeki K
    Jpn J Pharmacol; 1983 Dec; 33(6):1255-61. PubMed ID: 6199541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anomalous effects of disodium cromoglycate. A study on two secretory systems.
    Alm PE; Bloom GD; Henriksson R
    Int Arch Allergy Appl Immunol; 1981; 66(4):416-26. PubMed ID: 6170594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells.
    Hachisuka H; Nomura H; Sakamoto F; Mori O; Okubo K; Sasai Y
    Arch Dermatol Res; 1988; 280(3):158-62. PubMed ID: 2454082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the action of histamine release by persulphates.
    Parsons JF; Goodwin BF; Safford RJ
    Food Cosmet Toxicol; 1979 Apr; 17(2):129-35. PubMed ID: 89996
    [No Abstract]   [Full Text] [Related]  

  • 13. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release--a distinctive feature from disodium cromoglycate.
    Nabe T; Hashii H; Matsubara S; Yasui K; Yamamura H; Horiba M; Watanabe-Kohno S; Ohata K
    J Pharmacobiodyn; 1992 Dec; 15(12):673-9. PubMed ID: 1284281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action and indication for disodium cromoglycate (DSCG).
    Kunkel G; Baumer FE; Okuda M; van Cauwenberge P
    Allergol Immunopathol (Madr); 1985; 13(4):285-9. PubMed ID: 2417468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
    Goto K; Hisadome M; Terasawa M
    Int Arch Allergy Appl Immunol; 1982; 68(4):332-7. PubMed ID: 6178699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Chinese herbal medicines and disodium cromoglycate on IgE-dependent histamine release from mouse cultured mast cells.
    Shichijo K; Saito H
    Int J Immunopharmacol; 1997; 19(11-12):677-82. PubMed ID: 9669208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.